Showing 1461-1470 of 18586 results for "".
Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
https://reachmd.com/programs/project-oncology/immunotherapy-advances-in-early-stage-upper-gi-cancers/35503/Early-stage upper GI cancers carry a high risk of systemic spread, prompting a shift from conventional therapies to immunotherapy-based strategies. Given this evolving landscape, Dr. Ronan Kelly joins Dr. Jennifer Caudle to review landmark trials, including CheckMate 577 and MATTERHORN. Together, thIndividualizing gMG Treatment: Defining Success With Each Patient
https://reachmd.com/programs/neurofrontiers/individualizing-gmg-treatment-defining-success-with-each-patient/32862/As treatment options for generalized myasthenia gravis (gMG) expand, defining success means more than just controlling symptoms—it means aligning care with each patient’s goals and lifestyle. Hear Dr. Omar Sinno, who spoke with ReachMD at the AANEM 2025 Annual Meeting in San Francisco, share insightAssessing Nivolumab + Ipilimumab in mNSCLC: 6-Year Outcomes from CheckMate 9LA
https://reachmd.com/programs/project-oncology/assessing-nivolumab-ipilimumab-in-mnsclc-6-year-outcomes-from-checkmate-9la/35996/The CheckMate 9LA trial evaluated nivolumab plus ipilimumab with chemotherapy as a first-line treatment for metastatic non-small cell lung cancer (mNSCLC) in patients with low PD-L1 expression. The final, 6-year results show durable survival benefits, with nearly threefold higher long-term survivalInterdisciplinary Management of Gynecologic Cancers
https://reachmd.com/programs/cme/Interdisciplinary-Management-of-Gynecologic-Cancers/39286/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Supplements and Cannabis in Breast Cancer Care: An Integrative Medicine Approach
https://reachmd.com/programs/project-oncology/supplements-and-cannabis-in-breast-cancer-care-an-integrative-medicine-approach/26409/Here’s how we can use an integrative medicine approach to balance evidence-based guidance on supplements and cannabis with patients’ goals.Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
https://reachmd.com/programs/frontlines-iga-nephropathy/diagnosing-iga-nephropathy-the-role-of-immunofluorescence-and-immunohistochemistry/26943/How is IgA nephropathy diagnosed and differentiated from similar diseases? Tune in to find out.The Future of IgA Nephropathy: Why Biomarkers Matter
https://reachmd.com/programs/frontlines-iga-nephropathy/the-future-of-iga-nephropathy-why-biomarkers-matter/26942/Dive into the importance of biomarkers in the intensifying pursuit of newer, more effective treatments for IgA nephropathy.ISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024."A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
https://reachmd.com/programs/the-convergence/ultrasound-clement-papadacci-inserm/39926/4D ultrasound and ultrasound localization microscopy (ULM) are reshaping non-invasive imaging, allowing clinicians to visualize entire organs—down to vessels smaller than a human hair—in dynamic, real-time detail. Dr. Clément Papadacci joins Dr. Brian McDonough to share how his groundbreaking probeBringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
https://reachmd.com/programs/project-oncology/bringing-cancer-care-home-how-subcutaneous-immunotherapy-can-help-ease-the-burden/35770/As immunotherapy becomes a cornerstone for treating a growing number of solid tumors, reducing the logistical burden of in-office care is essential. Fortunately, the at-home administration of subcutaneous formulations of immunotherapy agents like atezolizumab could help transform the way we care for